Management of Lyme disease

References

• Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann. Intern. Med.86, 685–698 (1977).
   PubMed Web of Science ®Google Scholar
• US CDC. Lyme disease – United States, 2003–2005. MMWR Morb. Mortal. Wkly Rep.56(23), 573–576 (2007).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Lyme disease – United States, 2001–2002. MMWR Morb. Mortal. Wkly Rep.53(17), 365–369 (2004).
   PubMedGoogle Scholar
• Poland GA. Prevention of Lyme disease: a review of the evidence. Mayo Clin. Proc.76, 713–724 (2001).
   PubMedGoogle Scholar
• Smith RP. Current diagnosis and treatment of Lyme disease. Comp. Ther.31(4), 284–290 (2005).
   PubMedGoogle Scholar
• Burgdorfer W, Barbour AG, Hayes SF, Péter O, Aeschlimann A. Erythema chronicum migrans – a tick-borne spirochetosis. Acta Trop.40(1), 79–83 (1983).
   PubMed Web of Science ®Google Scholar
• Wormser GP, Stanek G, Strle F, Gray JS. Advances in the treatment and prevention of Lyme borreliosis. Wien. Klin. Wochenschr.117(11–12), 381–384 (2005).
   PubMedGoogle Scholar
• Hu LT, Klempner MS. Update on the prevention, diagnosis, and treatment of Lyme disease. Adv. Intern. Med.46, 247–275 (2001).
   PubMedGoogle Scholar
• Steere AC. Lyme borreliosis in 2005, 30 years after initial observations in Lyme connecticut. Wien. Klin. Wochenschr.118(21–22), 625–633 (2006).
   PubMed Web of Science ®Google Scholar
• Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect. Dis.3, 489–500 (2003).
   PubMed Web of Science ®Google Scholar
• Kurtenbach K, De Michelis S, Etti S et al. Host association of borrelia burgdorferi sensu lato – the key role of host complement. Trends Microbiol.10(2), 74–79 (2002).
   PubMed Web of Science ®Google Scholar
• Piesman J, Gern L. Lyme borreliosis in Europe and North America. Parasitology129, S191–S220 (2004).
   PubMed Web of Science ®Google Scholar
• Greer DM, Schaefer PW, Plotkin SR, Hasserjian, RP, Steere AC. Case 11–2007: a 59-year old man with neck pain, weakness in the arms, and cranial nerve palsies. N. Engl. J. Med.356(15), 1561–1570 (2007).
   PubMedGoogle Scholar
• Smith RP, Schoen RT, Rahn DW et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann. Intern. Med.136, 421–428 (2002).
   PubMed Web of Science ®Google Scholar
• Steere AC, Bartenhagen NH, Craft JE et al. The early clinical manifestations of Lyme disease. Ann. Intern. Med.99(1), 76–82 (1983).
   PubMed Web of Science ®Google Scholar
• Taylor RS, Simpson IN. Review of treatment options for Lyme borreliosis. J. Chemother.17(Suppl. 2), 3–16 (2005).
   PubMed Web of Science ®Google Scholar
• Stanek G, Strle F. Lyme borreliosis. Lancet362, 1639–1647 (2003).
   PubMed Web of Science ®Google Scholar
• Wormser GP, McKenna D, Carlin J et al. Brief communication: hematogenous dissemination in early Lyme disease. Ann. Intern. Med.142, 751–755 (2005).
   PubMedGoogle Scholar
• Pachner AR, Steiner I. Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol.6(6), 544–552 (2007).
   PubMed Web of Science ®Google Scholar
• Perkins MP, Shumway N, Jackson WL. Lyme neuroborreliosis presenting as the syndrome of inappropriate antidiuretic hormone secretion. MedGenMed8(3), 71 (2006).
   PubMedGoogle Scholar
• Shamim EA, Shamim SA, Liss G, Nylen E, Pincus JH, Yepes M. Constipation heralding neuroborreliosis. Arch. Neurol.62(4), 671–673 (2005).
   PubMedGoogle Scholar
• The ILADS Working group. Evidence-based guidelines for the management of Lyme disease. Expert Rev. Anti Infect. Ther.2(1), S1–S13 (2004).
   PubMedGoogle Scholar
• Wormser GP, Dattwyler RJ, Shapiro ED et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious disease society of America. Clin. Infect. Dis.43, 1089–1134 (2006).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Lautin A, Burrascano JJ. Lyme disease: point/counteroint. Expert Rev. Anti. Infect. Ther.3(2), 155–165 (2005).
   PubMedGoogle Scholar
• Yrjänäinen H, Hytönen J, Söderström KO, Oksi J, Hartiala K, Viljanen MK. Persistent joint swelling and borrelia-specific antibodies in Borrelia garinii-infected mice after eradication of vegetative spirochetes with antibiotic treatment. Microbes Infect.8(8), 2044–2051 (2006).
   PubMedGoogle Scholar
• Donta ST. Treatment of patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med.345(19), 1424 (2001).
   PubMedGoogle Scholar
• Phillips SE, Burrascano JJ, Harris NS, Johnson L, Smith PV, Stricker RB. Chronic infection in ‘post-Lyme borreliosis syndrome.’ Int. J. Epidemiol.34(6), 1439–1440 (2005).
   Google Scholar
• Cairns V, Goodwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int. J. Epidemiol.34(6), 1340–1345 (2005).
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Dattwyler R, Nadelman RB, Wormser GP. Response to meta-analysis of Lyme borreliosis symptoms. Int. J. Epidemiol.34(6), 1437–1439 (2005).
   PubMed Web of Science ®Google Scholar
• Winterholler M, Erbguth FJ. Tick bite induced respiratory failure. Intensive Care Med.27(6), 1095 (2001).
   PubMedGoogle Scholar
• Kirsch M, Ruben FL, Steere AC, Duray PH, Norden CW, Winkelstein A. Fatal adult respiratory distress syndrome in a patient with Lyme disease. J. Am. Med. Assoc.259(18), 2737–2739 (1998).
   Google Scholar
• Marcus LC, Steere AC, Duray PH, Anderson AE, Mahoney EB. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann. Intern. Med.103(3), 374–376 (1985).
   PubMed Web of Science ®Google Scholar
• Depietropaolo DL, Powers JH, Gill JM. Diagnosis of Lyme disease. Am. Fam. Physician72(2), 297–304 (2005).
   PubMedGoogle Scholar
• Feder HM, Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels J. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. Clin. Dermatol.24(6), 509–520 (2006).
   PubMedGoogle Scholar
• Wormser GP. Clinical practice. Early Lyme Disease. N. Engl. J. Med.354(26), 2794–2801 (2006).
   PubMed Web of Science ®Google Scholar
• Bakken LL, Callister SM, Wand PJ, Schell RF. Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygience/College of American Pathologists Proficiency Testing Program. J. Clin. Microbiol.35(3), 537–543 (1997).
   PubMedGoogle Scholar
• Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev.18(3), 484–509 (2005).
   PubMed Web of Science ®Google Scholar
• Dumler JS. Molecular diagnosis of Lyme disease: review and meta-analysis. Mol. Diagn.6(1), 1–11 (2001).
   PubMedGoogle Scholar
• Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol. Med. Microbiol.49(1), 13–21 (2007).
   PubMedGoogle Scholar
• Nocton JJ, Bloom BJ, Rutledge BJ et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J. Infect. Dis.174(3), 623–627 (1996).
   PubMed Web of Science ®Google Scholar
• Keller TL, Halperin JJ, Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology42, 32–42 (1992).
   PubMed Web of Science ®Google Scholar
• Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin. Microbiol. Rev.10(1), 185–201 (1997).
   PubMed Web of Science ®Google Scholar
• Cameron DJ. Consequences of treatment delay in Lyme disease. J. Eval. Clin. Pract.13(3), 470–472 (2007).
   PubMed Web of Science ®Google Scholar
• Nadelman RB, Nowkowski J, Fish D et al. Prophylaxis with single dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N. Engl. J. Med.345(2), 79–84 (2001).
   PubMed Web of Science ®Google Scholar
• Wormser GP, Dattwyler RJ, Shapiro ED et al. Single-dose prophylaxis against Lyme disease. Lancet Infect. Dis.7(6), 371–373 (2007).
   PubMedGoogle Scholar
• Dinser R, Jendro MC, Schnarr S, Zeidler H. Antibiotic treatment of Lyme borreliosis: what is the evidence? Ann. Rheum. Dis.64, 519–523 (2005).
   PubMedGoogle Scholar
• Wormser GP, Nadelman RB, Dattwyler RJ et al. Practice guidelines for the treatment of Lyme disease. Clin. Infect. Dis.31(Suppl. 1), S1–S14 (2003).
   Google Scholar
• The Medical Letter. Treatment of Lyme disease. Med. Lett. Drugs Ther.46(1209), 41–43 (2005).
   Google Scholar
• Wormser GP, Ramanathan R, Nowakowski J et al. Duration of antibiotic therapy for early Lyme disease, a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med.138(9), 697–704 (2003).
   PubMed Web of Science ®Google Scholar
• Hunfeld KP, Brade V. Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don’t know, and what we need to know. Wien. Klin. Wochenschr.118(21–22), 659–668 (2006).
   PubMed Web of Science ®Google Scholar
• Ogrinc K, Logar M, Lotric-Furlan S, Cerar D, Ružic-Sabljic E, Strle F. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis. Wien. Klin. Wochenschr.118(21–22), 696–701 (2006).
   PubMedGoogle Scholar
• Halperin JJ, Shapiro ED, Logigian E et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review). Neurology69, 1–12 (2007).
   Google Scholar
• Oksi J, Nikoskelainen J, Hiekkanen H et al. Duration of anti-biotic treatment in disseminated Lyme borreliosis: a double-blind; randomized, placebo-controlled, multicenter clinical study. Eur. J. Clin. Microbiol. Infect. Dis.26, 571–581 (2007).
   PubMed Web of Science ®Google Scholar
• Steere AC, Angelis SM. Therapy for Lyme arthritis. Arthritis Rheum.54(10), 3079–3086 (2006).
   PubMed Web of Science ®Google Scholar
• Cimmino MA, Sambri V, Massaria F, Accardo S. An in-vitro study of the susceptibility of Borrelia burgdorferi to hydroxychloroquine sulfate. Clin. Exp. Rheumatol.12, 461–462 (1994).
   PubMedGoogle Scholar
• Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine. Int. Microbiol.5(1), 25–31 (2002).
   PubMedGoogle Scholar
• Dattwyler RJ, Wormser GP, Rush TJ et al. A comparison of two treatment regimes of ceftriaxone in late Lyme disease. Wien. Klin. Wochenschr.117(11–12), 393–397 (2005).
   PubMed Web of Science ®Google Scholar
• Krupp LB, Hyman LG, Grimson R et al. Study and treatment of post Lyme disease (STOP-LD): a randomized, double masked clinical trial. Neurology60, 1923–1930 (2003).
   PubMed Web of Science ®Google Scholar
• Klempner MS, Hu LT, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med.345(2), 85–92 (2001).
   PubMed Web of Science ®Google Scholar
• Donta S. Treatment of patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med.345(19), 1424–1425 (2001).
   PubMedGoogle Scholar
• Feder HM, Johnson BJ, O’Connell S et al. A critical appraisal of ‘chronic Lyme disease.’ N. Engl. J. Med.357(14), 1422–1430 (2007).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Johnson L. Lyme disease: a turning point. Expert Rev. Anti Infect. Ther.5(5), 759–762 (2007).
   PubMed Web of Science ®Google Scholar
• Hayes EB, Piesman J. How can we prevent Lyme disease? N. Engl. J. Med.348(24), 2424–2430 (2003).
   PubMed Web of Science ®Google Scholar
• Corapi KM, White MI, Phillips CB, Daltroy LH, Shadick NA, Liang MH. Strategies for primary and secondary prevention of Lyme disease. Nat. Clin. Pract. Rheumatol.3(1), 20–25 (2007).
   PubMedGoogle Scholar
• Couch P, Johnson CE. Prevention of Lyme disease. Am. J. Hosp. Pharm.49(5), 1164–1173 (1992).
   PubMedGoogle Scholar
• American Academy of Pediatrics. Committee on Infectious Diseases. Prevention of Lyme disease. Pediatrics105(1), 142–147 (2000).
   PubMedGoogle Scholar
• Daltroy LH, Phillips C, Lew R et al. A controlled trial of a novel prevention program for Lyme and other tick-borne illnesses. Health Educ. Behav.34, 531–542 (2007).
   PubMed Web of Science ®Google Scholar
• Hsia E, Chung J, Sanford-Schwartz J, Albert D. Cost-effectiveness analysis of the Lyme disease vaccine. Arthritis Rheum.46(6), 1651–1660 (2002).
   PubMed Web of Science ®Google Scholar
• Sigal L.Vaccination for Lyme disease: cost–effectiveness versus cost and value. Arthritis Rheum.46(6), 1439–1442 (2002).
   PubMed Web of Science ®Google Scholar
• Abbott A. Uphill struggle. Nature439, 524–525 (2006).
   PubMed Web of Science ®Google Scholar
• US CDC. Recommendations for the use of Lyme disease vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.48(RR-7), 1–17, 21–25 (1999).
   Google Scholar
• Shadick N, Liang M, Phillips C, Fossel K, Kuntz K. The cost–effectiveness of vaccination against Lyme disease. Arch. Intern. Med.161, 554–561 (1991).
   Google Scholar